miR-153 suppresses angiogenesis through targeting HIF1α as well as negative regulation of ANG1 and inhibition of endothelial cell tube formation and migration in breast cancer (Figure 3) (67, 80, 81). The gene discussed is ANGPT1; the disease is breast cancer.